Clinical Trial Update: PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on PEG-rhG-CSF for lymphoma patients after autologous hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: Peking University | Conditions: Lymphoma | Phase 4 | Status: UNKNOWN